Santen Pharmaceutical Co., Ltd. held its 91st Annual General Meeting of Shareholders on June 26, 2003. The Meeting started at 10:00 a.m. and ended at 11:07 a.m. The number of shareholders attended was 118.

 

Matters reported	Santen reported the non-consolidated balance sheets as of March 31, 2003, and the non-consolidated statements of income and operational review for the 91st business term (April 1, 2002 to March 31, 2003).
Matters resolved	Eight items of business as described below were resolved. Resolution (PDF: 13KB)PDF file.Page will open in a new window.
Questions	Three shareholders submitted the following questions and the Board of Directors answered each question. Sales strategy for OTC eye drops Details of the loss from liquidation of a subsidiary Outlook for overseas business Factor for decreased earnings per share and countermeasures